DUBLIN – (COMMERCIAL THREAD) – The “Global Unicellular Analysis Market by cell type (human, animal, microbial), product (consumables, instrument), technique (flow cytometry, NGS, PCR, microscopy, MS), application (research, medical), End user (Pharma, Biotech, Hospitals) – Forecast to 2026 report “has been added to ResearchAndMarkets.com offer.

The global single-cell analysis market is expected to reach USD 6.3 billion by 2026, from USD 3.1 billion in 2021, at a CAGR of 15.1% during the forecast period.

The growth of the single cell assay market can be mainly attributed to factors such as technological advancements in single cell assay products, increasing prevalence of cancer, increasing R&D in pharmaceutical and biotechnology industries for diseases complex, stem cell research growth and growth focus on personalized medicine. On the other hand, the high cost of single cell analysis instruments is expected to hamper the market growth to some extent.

Consumables segment accounted for the highest growth rate in the Single Cell Analysis market, by product, during the forecast period

Consumables accounted for the largest share of 67.4% of the single cell analysis market in 2020. The large share of this segment can mainly be attributed to the frequent purchase of these products compared to instruments, which are considered as a one-time investment. The wide applications of the consumables in genetic research and exploration, exosome analysis, and RNA and DNA isolation are also expected to drive the market growth.

The human cell segment accounted for the largest share

The single cell analysis market is segmented into human cells, animal cells, and microbial cells. The human cell segment accounted for the largest share of 51.6% of the single cell analysis market in 2020. The large share of this segment can be attributed to the high use of human cells in research laboratories and academic institutes. .

Asia-Pacific: Fastest Growing Region in Single Cell Analysis Market

The Asia-Pacific region market is expected to grow at the highest CAGR of 17.4% during the forecast period. This can be attributed to the rapid growth of the pharmaceutical industry in this region, the increase in the geriatric population, the increase in the prevalence of cancer, and the increase in government initiatives.

The major players in single cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN NV (Netherlands), Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Illumina, Inc. (US), Fluidigm Corporation (US), 10x Genomics (US), and Corning Incorporated (US) ).

Premium previews

  • Technological Advancements in Single Cell Analysis Products to Support Market Growth

  • Consumables accounted for the largest share of the North American single-cell analysis market in 2020

  • Consumables will continue to dominate the single cell analysis market in 2026

  • University and research laboratories accounted for the largest market share in 2020

  • Asia Pacific to Record Highest Growth in Single Cell Analysis Market from 2021 to 2026

Market dynamics

Conductors

  • Technological Advances in Single Cell Analysis Products

  • Increased prevalence of cancer

  • Increase R&D in the pharmaceutical and biotechnology industries for complex diseases

  • Growth of stem cell research

  • Growing focus on personalized medicine

Constraints

  • High cost of single cell assay products

Opportunities

  • High growth potential of single-cell sequencing

  • Integration of microfluidics in unicellular analysis

  • Emerging Asian Markets

Company Profiles

Key companies

  • Becton, Dickinson and company

  • Danaher Company

  • Merck KgaA

  • Thermo Fisher Scientific, Inc.

  • Qiagen SA

  • 10X Genomics

  • Promega Company

  • Illumina

  • Bio-Rad Laboratories

  • Fluidigm Corporation

  • AGilent Technologies, Inc.

  • Corning Incorporated

  • Takara Bio Inc.

  • Biomérieux SA

  • Groupe Tecan Ltée.

  • Sartorius SA

  • Luminex Company

Other players

  • Oxford Nanopore Technologies

  • Cytek Biosciences

  • Fluxion Biosciences

  • Menarini silicon biosystems

  • Apogee Flow Systems Ltd.

  • Biomedical nanocell

  • Biotechnology on a Chip Co., Ltd.

  • Rarecyte, Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/tw03qc


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *